A prospective observational study of real world use of BOTOX for the management of urinary incontinence in patients with Idiopathic OAB 'GRACE 2'

Trial Profile

A prospective observational study of real world use of BOTOX for the management of urinary incontinence in patients with Idiopathic OAB 'GRACE 2'

Completed
Phase of Trial: Phase IV

Latest Information Update: 17 Jun 2016

At a glance

  • Drugs Botulinum toxin A (Primary)
  • Indications Urinary incontinence
  • Focus Therapeutic Use
  • Acronyms GRACE2
  • Sponsors Allergan
  • Most Recent Events

    • 08 Jun 2016 Status changed from active, no longer recruiting to completed.
    • 15 Mar 2016 Status changed from recruiting to active, no longer recruiting, according to United Kingdom Clinical Research Network record.
    • 27 Oct 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top